maintain hold follow mix result mark in-lin
kidney care volum natx stabl commerci mix solid buy-back
activ addit make headway dmg sale continu
expect break even intern oi year end full year guidanc
re-affirmed includ almost non-recur benefit
trim estim given lower recur base addit
issu bear watch labor ca union view risk/reward balanc
maintain hold price target adj ebitda
result bit behind organ trend solid normal
natx growth in-lin expect despit oper
chang quarter tie shift calcimimet reimburs
part part result revenue/treat increas
sequenti tie calcimimet reimburs tie
bad debt recoveri cost/treat increas calcimimet
primari driver addit uptick labor match
higher payrol tax adjust oper incom ex non-
adjust ebit shi
new leadership streamlin initi
place intern post oper profit adjust fx
loss asia-pacif jv addit manag reiter expect
break even oper incom continu view segment
attract area opportun potenti area increas capit
deploy vehicl diversifi compani time
detail flow continu oper free cash
flow continu oper came
estim tie increas a/r chang calcimimet
bill season decreas accru compens
addit compani repurchas share
addit sinc quarter end leav avail
current author compani help financ share repurchas
new term loan meaning expect proce dmg
sale see opportun aggress capit deploy
reiter capital-expenditure expect includ one
time invest return normal level
guidanc includ kidney oi cffo
bump oi includ
tr target
benefit non-recur item trim oi
estim impli oi growth recur
page
revenu
revenu
revenu
revenu
revenu
amort net tax
page
base denver co davita healthcar partner inc lead provid dialysi servic
unit state patient suffer chronic kidney failur end stage renal diseas esrd
compani enter agreement sell davita medic group optum
transact expect close
continu like core dialysi busi acknowledg potenti opportun tie
integr care longer term think dmg segment higher oper variabl increas
risk suggest lower multipl profit stream continu concern relat
premium assist remain upbeat potenti long-term opportun improv
trend dmg remain key
valuat risk
price target base trade adjust ebitda discount
industri peer freseniu medic view appropri given less product geograph
diversif risk price target upsid includ better expect reimburs
oper perform downsid risk includ wors expect reimburs pressur
slow organ trend
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
